RA
NRXS icon

Rosalind Advisors’s Neuraxis NRXS Stock Holding History

Rosalind Advisors’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Buy
508,055
+221,917
+78% +$1.64M 1.1% 19
2026
Q1 		$1.69M Hold
286,138
– – 0.68% 27
2025
Q4 		$1.04M Buy
+286,138
New +$855K 0.37% 31

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $167M AUM

Rosalind Advisors's NRXS Position: Q2 2026 in Review

Rosalind Advisors increased its Neuraxis (NRXS) stake by 78% in Q2 2026, buying an estimated $1.64M and bringing the position to 508,055 shares worth $2.97M. The position accounts for 1.1% of the portfolio, ranked #19.

Rosalind Advisors first reported a position in NRXS in Q4 2025 and has held it in 3 quarters since. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Rosalind Advisors held 508,055 shares of Neuraxis worth $2.97M as of Q2 2026.
  • Rosalind Advisors bought 221,917 Neuraxis shares in Q2 2026, an estimated $1.64M.
  • Neuraxis made up 1.1% of Rosalind Advisors's portfolio in Q2 2026, its #19 holding.
  • Rosalind Advisors first reported a position in Neuraxis in Q4 2025 and has held it in 3 quarters since.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.